🔍
Search Results - technology+classifications+%3e+research+tools+%3e+nucleic+acids
45
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A method for inhibiting UHRF1 in colorectal cancer
Value PropositionReversal of colorectal cancer-specific DNA hypermethylationmRNA-based strategy for UHRF1 inhibitionA lipid nanoparticle-based delivery platformUnmet Need1 out of 24 people will develop colorectal cancer. Current technologies do not maximize the bodies’ native ability to suppress tumors. Existing therapies lack specificity and cause...
Published: 9/12/2025
|
Inventor(s):
Stephen Baylin
,
Srinivasan Yegnasubramanian
,
Ying Cui
,
Xiangqian Kong
Keywords(s):
Category(s):
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
,
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Therapeutic Modalities > Peptides
,
Technology Classifications > Therapeutic Modalities > Proteins
,
Technology Classifications > Research Tools > Proteins, Ligands & Receptors
Method for Continuous, Sub-second-resolved, Drift-free and Real-time Interrogation of DNA-based Electrochemical Sensors based on Cyclic Voltammetry
Value Proposition:· Improves temporal stability, reducing batch-to-batch as well as day-to-day variability in sensor performance. · Is drift-free and calibration-free, unlike traditional pulse voltammetry. · Provides additional sensor capacitance information that can report on monolayer stability over time.· Allows for continuous...
Published: 9/12/2025
|
Inventor(s):
Netzahualcoyotl Arroyo
,
Miguel Aller Pellitero
,
Jonathan Mahlum
,
Samuel Curtis
Keywords(s):
Category(s):
Technology Classifications > Computers, Electronics & Software > Sensors
,
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Research Tools > Assays
Short Viral RNAs (svRNAs) with Theragnostic Potential in Infection with SARS-CoV-2 and Related Viruses
Value PropositionNovel Biomarkers for Diagnosis & PrognosisInsights into viral immune evasion mechanism Identify key host pathways targeted by svRNAs Novel Therapeutic TargetsIdentified pathways enable the development of immune-modulating therapies. Unmet NeedStudies have show than SARS-CoV-2 employs various mechanisms to evade the host’s innate...
Published: 9/12/2025
|
Inventor(s):
Kenneth Witwer
,
Tom Driedonks
,
Andrey Turchinovich
Keywords(s):
Category(s):
Clinical and Disease Specializations > Infectious Diseases > Covid-19
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Research Tools > Nucleic Acids
,
Clinical and Disease Specializations > Infectious Diseases
Light-controllable Helicases
Value Proposition· Enhanced accuracy: These enzymes may be used to more accurately sequence DNA · Study control: light activated enzymes may be used for precise manipulation of helicases to be used for in-cell studies.Unmet Need· The enzymatic activity for DNA transcription and translation is frequently used in research and commercial...
Published: 9/12/2025
|
Inventor(s):
Taekjip Ha
,
Dmitriy Bobrovnikov
,
Yann Chemla
,
Monika Makurath
Keywords(s):
Category(s):
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Research Tools > Assays
Methods for in situ Detection of DNA Sequence Variation
Value Proposition· High-throughput· Assess genetic variants with simultaneous spatial analysis· Interrogate over 100 variants in a single assayUnmet Need· Next generation sequencing has led to an ever-proliferating dearth of genetic information. More recent progress in nucleoside tissue analysis has birthed the field of spatial...
Published: 9/12/2025
|
Inventor(s):
Reza Kalhor
,
Soichiro Asami
Keywords(s):
Category(s):
Technology Classifications
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Research Tools > Assays
,
Technology Classifications > Research Tools > Antibodies
,
Technology Classifications > Research Tools > Bioinformatics
,
Technology Classifications > Research Tools > Imaging
,
Technology Classifications > Research Tools > Nucleic Acids
Composition of Media with Defined Fluid Viscosity for Enhancing Intracellular Delivery of Nanoparticles and Viral Vectors, and Methods of Use
Unmet Need· Production of gene therapies, cell therapies, and recombinant proteins are largely dependent on efficient transfection using viral vectors or nanoparticle vehicles to deliver genetic cargo. However, although numerous transfection reagents have been developed, many strategies still suffer from low efficiency in particular cell-lines...
Published: 9/12/2025
|
Inventor(s):
Hai-Quan Mao
,
Yining Zhu
,
Jingyao Ma
,
Sean Sun
,
Zhuoxu Ge
,
Qin Ni
Keywords(s):
Category(s):
Technology Classifications > Research Tools > Buffers & Media Solutions
,
Technology Classifications > Research Tools > Vectors & Plasmids
,
Technology Classifications > Research Tools > Viruses
,
Technology Classifications > Research Tools > Nucleic Acids
Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles
Value Proposition:· Technology creates particles optimally size for use as vehicles for cell transfection.· The reagents and processes for particle creation are kinetically controlled and reproducible.· Cationic particles created using these methods can carry larger payloads than current vehicles.· Reagents and nucleic acid-loaded...
Published: 9/12/2025
|
Inventor(s):
Hai-Quan Mao
,
Yizong Hu
,
Jinghan Lin
Keywords(s):
Category(s):
Technology Classifications > Engineering Tech > Bioreactors
,
Technology Classifications > Engineering Tech > Materials
,
Technology Classifications > Industrial Tech > Bioreactors
,
Technology Classifications > Research Tools > Buffers & Media Solutions
,
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Research Tools > Peptides
,
Technology Classifications > Research Tools > Vectors & Plasmids
,
Technology Classifications > Research Tools > Cell Lines
,
Technology Classifications > Therapeutic Modalities > Gene Therapies
,
Technology Classifications > Therapeutic Modalities > Cell Therapies
,
Technology Classifications > Therapeutic Modalities > Peptides
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
Targeted capture of custom nucleotide sequences for single-cell sequencing
Value Proposition· Implementation only requires simple modification of current capture beads.· Allows for targeting of custom sequences of interest that may be cell-type specific or expressed at low levels.· Targets RNA molecules without polyA tails.· Inexpensive modification to existing commercial methods. Technology DescriptionResearchers...
Published: 9/12/2025
|
Inventor(s):
Jonathan Ling
,
Katherine Irwin
,
Irika Sinha
,
Philip Wong
,
Linda Orzolek
,
Tyler Creamer
Keywords(s):
Category(s):
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Research Tools > Vectors & Plasmids
,
Technology Classifications > Research Tools > Assays
Organo-phosphate Modified Metal Organic Frameworks and Applications
Marketing Summary Draft #C17480 Organo-phosphate Modified Metal Organic Frameworks and ApplicationsInventors: Michael Tsapatsis, Efrosini Kokkoli, Danyu WangUnmet NeedThere is a continuously growing need for new and better asymmetric catalysts, as is evidenced by the fact that the 2021 Nobel Prize in Chemistry went to two scientists for development...
Published: 9/12/2025
|
Inventor(s):
Michael Tsapatsis
,
Efrosini Kokkoli
,
Danyu Wang
Keywords(s):
Category(s):
Technology Classifications > Research Tools > Nucleic Acids
,
Technology Classifications > Engineering Tech > Materials
,
Technology Classifications > Therapeutic Modalities
,
Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms
,
Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers
CRISPR/Cas9 and Tumor-Specific Guide RNAs as a Specific and Selective Cancer Cell Killing Biologic Platform
Value Proposition:Specific targeting of mutations can treat any cancer with the specified mutations.Selective cell killing spares healthy tissue while eliminating cancer cells. Pan-cancer efficacy as guide RNAs are developed to target a wide breadth of cancer-specific mutations.Lack of protospacer adjacent motif (PAM) sites in healthy host cells prevents...
Published: 9/12/2025
|
Inventor(s):
James Eshleman
,
Selina Shiqing Teh
,
Kirsten Bowland
,
Nicholas Roberts
Keywords(s):
Category(s):
Clinical and Disease Specializations > Oncology
,
Clinical and Disease Specializations > Oncology > Pancreatic Ductal Adenocarcinoma
,
Clinical and Disease Specializations > Oncology > Pancreatic Cancer
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Research Tools > Nucleic Acids
1
2
3
4
5
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum